BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 10885618)

  • 1. In vitro markers and biological activity in mice of seed lot strains and commercial Brucella melitensis Rev 1 and Brucella abortus B19 vaccines.
    Grilló MJ; Bosseray N; Blasco JM
    Biologicals; 2000 Jun; 28(2):119-27. PubMed ID: 10885618
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of Brucella abortus S19 vaccine strains by bacteriological tests, molecular analysis of ery loci and virulence in BALB/c mice.
    Mukherjee F; Jain J; Grilló MJ; Blasco JM; Nair M
    Biologicals; 2005 Sep; 33(3):153-60. PubMed ID: 16081301
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enhanced efficacy of recombinant Brucella abortus RB51 vaccines against B. melitensis infection in mice.
    Vemulapalli R; Contreras A; Sanakkayala N; Sriranganathan N; Boyle SM; Schurig GG
    Vet Microbiol; 2004 Sep; 102(3-4):237-45. PubMed ID: 15327798
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serological findings obtained in cattle herds immunised with the Brucella melitensis Rev.1 and the B. abortus B19 vaccine in Mongolia.
    Dénes B
    Acta Vet Hung; 1997; 45(1):33-43. PubMed ID: 9270127
    [TBL] [Abstract][Full Text] [Related]  

  • 5. B. melitensis rough strain B115 is protective against heterologous Brucella spp. infections.
    Adone R; Francia M; Pistoia C; Pesciaroli M; Pasquali P
    Vaccine; 2011 Mar; 29(14):2523-9. PubMed ID: 21300102
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development and evaluation as vaccines in mice of Brucella melitensis Rev.1 single and double deletion mutants of the bp26 and omp31 genes coding for antigens of diagnostic significance in ovine brucellosis.
    Cloeckaert A; Jacques I; Grilló MJ; Marín CM; Grayon M; Blasco JM; Verger JM
    Vaccine; 2004 Jul; 22(21-22):2827-35. PubMed ID: 15246618
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Immunobiological characteristics of Brucella outer membrane proteins, genetic determinants of which are expressed in Escherichia coli cells].
    Seliutina DF; Malikov VE; Chibisova VA; Gorelov VN; Skavronskaia AG
    Mol Gen Mikrobiol Virusol; 1993; (1):17-20. PubMed ID: 8510678
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Statistical procedures for calculating the residual virulence of Brucella abortus strain 19 (S19) and Brucella melitensis strain Rev 1 vaccines in mice: theoretical basis and practical applications.
    Pouillot R; Grilló MJ; Alabart JL; Garin-Bastuji B; Blasco JM
    Rev Sci Tech; 2003 Dec; 22(3):1051-63. PubMed ID: 15005562
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rough mutants defective in core and O-polysaccharide synthesis and export induce antibodies reacting in an indirect ELISA with smooth lipopolysaccharide and are less effective than Rev 1 vaccine against Brucella melitensis infection of sheep.
    Barrio MB; Grilló MJ; Muñoz PM; Jacques I; González D; de Miguel MJ; Marín CM; Barberán M; Letesson JJ; Gorvel JP; Moriyón I; Blasco JM; Zygmunt MS
    Vaccine; 2009 Mar; 27(11):1741-9. PubMed ID: 19186196
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Brucella suis S2, brucella melitensis Rev. 1 and Brucella abortus S19 living vaccines: residual virulence and immunity induced against three Brucella species challenge strains in mice.
    Bosseray N; Plommet M
    Vaccine; 1990 Oct; 8(5):462-8. PubMed ID: 2123586
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy of several antibiotic combinations against Brucella melitensis Rev 1 experimental infection in BALB/c mice.
    Grilló MJ; De Miguel MJ; Muñoz PM; Marín CM; Ariza J; Blasco JM
    J Antimicrob Chemother; 2006 Sep; 58(3):622-6. PubMed ID: 16849379
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serological and allergic reactions of ewes after simultaneous vaccinations with two living attenuated strains of Brucella and Salmonella.
    Pardon P; Sanchis R; Molenat G; Marly J; Renard D
    Ann Rech Vet; 1990; 21(2):153-60. PubMed ID: 2360774
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Assessment of genetic stability of Brucella melitensis Rev 1 vaccine strain by multiple-locus variable-number tandem repeat analysis.
    García-Yoldi D; Le Fleche P; Marín CM; De Miguel MJ; Muñoz PM; Vergnaud G; López-Goñi I
    Vaccine; 2007 Apr; 25(15):2858-62. PubMed ID: 17050051
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of Brucella melitensis B115 as rough-phenotype vaccine against B. melitensis and B. ovis infections.
    Adone R; Francia M; Ciuchini F
    Vaccine; 2008 Sep; 26(38):4913-7. PubMed ID: 18675869
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increases of efficacy as vaccine against Brucella abortus infection in mice by simultaneous inoculation with avirulent smooth bvrS/bvrR and rough wbkA mutants.
    Grilló MJ; Manterola L; de Miguel MJ; Muñoz PM; Blasco JM; Moriyón I; López-Goñi I
    Vaccine; 2006 Apr; 24(15):2910-6. PubMed ID: 16439039
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunological responses and protective efficacy against Brucella melitensis induced by bp26 and omp31 B. melitensis Rev.1 deletion mutants in sheep.
    Jacques I; Verger JM; Laroucau K; Grayon M; Vizcaino N; Peix A; Cortade F; Carreras F; Guilloteau LA
    Vaccine; 2007 Jan; 25(5):794-805. PubMed ID: 17070627
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of P39 gene deletion in live Brucella vaccine strains on residual virulence and protective activity in mice.
    Tibor A; Jacques I; Guilloteau L; Verger JM; Grayon M; Wansard V; Letesson JJ
    Infect Immun; 1998 Nov; 66(11):5561-4. PubMed ID: 9784574
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Residual virulence and immunogenicity of CGV26 and CGV2631 B. melitensis Rev. 1 deletion mutant strains in sheep after subcutaneous or conjunctival vaccination.
    Guilloteau LA; Laroucau K; Olivier M; Grillo MJ; Marin CM; Verger JM; Blasco JM
    Vaccine; 2006 Apr; 24(17):3461-8. PubMed ID: 16519974
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transcriptomic analysis of smooth versus rough Brucella melitensis Rev.1 vaccine strains reveals insights into virulence attenuation.
    Salmon-Divon M; Kornspan D
    Int J Med Microbiol; 2020 Jan; 310(1):151363. PubMed ID: 31699441
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Theoretical, practical and statistical basis for a general control method of activity for anti-Brucella vaccines.
    Bosseray N; Plommet AM; Plommet M
    Dev Biol Stand; 1984; 56():257-70. PubMed ID: 6489617
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.